MediNect Ophtho offers focused retinal disease research solutions tailored to SME biotechnology companies in the preclinical therapeutics’ development phase. We work in a highly collaborative way to maximise the value of your studies, regardless of the stage you are currently at. We have a lean and dedicated team that comprises a group of experts, including industry principal scientists and senior academics who have successfully navigated preclinical programs to clinical trials. Additionally, we have researchers with over 15 years of experience in conducting technically demanding in vivo techniques. 

www.medinect.co.uk